Haleon, the Sensodyne maker, saw its shares plunge. Weak cold-and-flu demand, a disruption to Chinese imports and softer consumer spending forced the company to cut its growth outlook again.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
Open a keyword to see other news on the same topic.
Related news
- Prediction: These 3 Dividend Stocks Will Raise Their Payouts No Matter What the Market Does
The article names three dividend payers with long records: WD-40 (paid dividends for 40 years), Energizer (quarterly dividend held at $0.30 since 2019, yield near 5.9%), and Haleon (interim dividend raised 9% this year). WD-40 is cited for its entrenched single product, low leverage (debt-to-EBITDA below 1), and roughly $80 million in annual free cash flow against a payout ratio in the mid-60% range. Energizer's reported payout tops 100%, but about $105 million of free cash flow in the first nine months of fiscal 2026 covered dividends while it repaid over $100 million of debt. Haleon keeps its payout ratio at 30% to 50%, generated about £769 million (roughly $1.02 billion) of free cash flow in the first half of 2026, and carries net debt near 2.5 times adjusted EBITDA, which it calls sustainable. The author argues these companies sell products people buy in any economy.
- If a Bear Market Is Coming, History Says These Stocks Could Be the Smartest to Own
The article argues that bear markets are a normal part of investing and that preparing before a downturn is key. It highlights Johnson & Johnson, Medtronic, Coca-Cola and Procter & Gamble as stocks to consider because they operate in economically resilient industries and have long dividend records. Yields cited are about 2% for J&J, 3% for Medtronic, 2.2% for Coca-Cola and 2.7% for P&G, with Coca-Cola's organic sales up 6% in Q2 2026 and P&G's up 4% in fiscal Q1 2027. A chart in the article shows that during the Great Recession, consumer staples and healthcare fell less than the broader market and recovered more strongly afterward. The article notes that past performance does not guarantee future results.
- Goldman says play defense with these stocks if you're worried about the AI bull failing
Goldman Sachs says investors worried that the AI trade may lose momentum should look to defensive stocks in health care and consumer staples, especially high-quality names that have recently lagged the market. Analysts led by Ben Snider note that Goldman's cyclicals-vs-defensives pair has fallen 6% over the past two weeks, and that AI capital spending now contributes about half of S&P 500 earnings growth, a share expected to shrink as spending slows. Among the stocks on Goldman's screen, Tyson Foods has an 11% trailing four-quarter free cash flow yield, the highest on the list, though its shares are down nearly 17% over six months. CVS Health has a 9% free cash flow yield and is up 15% this year but down 15% over the past three months. Goldman's base case still calls for continued earnings growth, and it sees possible catch-up gains in beaten-down consumer stocks in 2027, supported by lower energy prices and falling interest rates.
- I Just Invested $4,600 Across 3 Top Dividend Stocks. Here’s What I’m Loading Up on Right Now.
The author says they are shifting toward a more defensive portfolio due to warning signs, including the CAPE ratio at its second-highest level in history, soaring margin debt, persistent inflation, and the Fed's recent first rate hike in three years. They sold several lower-conviction holdings and invested over $4,600 in Abbott (ABT), Procter & Gamble (PG) and Paychex (PAYX). Citing Ned Davis Research and Hartford Funds data, dividend growers averaged a 10.2% annual total return over the past 50 years versus 4.2% for non-payers, with a lower average beta (0.89 vs. 1.18). The picks rest on durable cash flows and rising dividends: Abbott has raised its dividend for 54 consecutive years and yields 2.4%, P&G has 70 straight years of increases and a yield of nearly 2.8%, and Paychex yields 4.3% after a 10% hike.
- What If You’d Bought Vanguard’s Growth ETF at the Worst Possible Moment?
A $10,000 investment in VUG on Oct 31, 2007, which fell 51% at its low, is now worth $100,122, or about 13% a year, versus $71,189 in SPY. The Nov 19, 2021 peak fell 36% and took 795 days to recover; it is now worth $17,350 against $17,742 in SPY, the only tested entry point where VUG still trails the S&P 500. A 23% drop in early 2025 during the tariff sell-off recovered in 125 days, leaving the holding roughly even with SPY at $12,959 versus $12,944. The predecessor Vanguard Growth Index Fund Investor Shares, bought at the Mar 27, 2000 peak, took about 12.5 years to break even after a 56% decline. The article says VUG best suits investors with at least a decade ahead, since its top holdings NVIDIA, Apple and Microsoft make up 36% of the fund.
- I’m Making a Contrarian Bet on Oracle at What Seems Like The Worst Moment Possible
The author says he bought more Oracle shares again, as the stock closed at $141.40, down 51.75% over one year and 26.49% year to date. He points to remaining performance obligations of $664 billion, up $209 billion year over year, and cloud infrastructure revenue that rose 121% to $7.39 billion. Oracle trades at a forward P/E of 18, below Microsoft's 25 and Amazon's 24, while paying a $0.50 quarterly dividend with a 1.48% yield. The main risk he watches is negative free cash flow of -$5.40 billion, as capex rose 235.2% to $28.50 billion, interest expense climbed 55% and a $20 billion equity issuance diluted his stake. He argues that operating cash flow rose 183.82% to $23.10 billion and that most new contracts require no additional Oracle capital, which keeps his buying thesis intact.
Related markets
Latest news
- Anthropic IPO: 1,300% Growth, $16.3 Billion in Revenue, and an $80.7 Billion Loss. Here Are the Numbers to Watch.
Anthropic plans its public debut next month, seeking to raise $100 billion in what could be the largest IPO ever, which would surpass the June listing of Space Exploration Technologies (SPCX). Its S-1 shows revenue grew from $41 million in 2023 to $386 million in 2024 and about $4.6 billion in 2025, reaching $16.3 billion in the first half of 2026, more than 1,300% above the same period of 2025. Third-quarter results were not included, and recent reports suggest growth slowed then. The first-half net loss of $80.7 billion mostly reflects a $72.4 billion non-cash charge tied to revaluing convertible debt; the operating loss narrowed to $693 million from $2.1 billion a year earlier, and the company posted a $974 million operating profit in the second quarter. Anthropic also has roughly $750 billion in spending commitments to compute providers and chipmakers, most of them non-cancelable, which the article says could leave it in a tight financial position if sales projections prove too optimistic.
- Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030
The article projects the value of investing $100 per month in Eli Lilly (LLY) stock through late 2030, about four years. Assuming annual growth of 25%, a more conservative figure than growth above 30%, the $4,800 invested could be worth close to $8,000, a gain of roughly 67%. Growth is driven by GLP-1 weight-loss drugs Mounjaro and Zepbound, with Morgan Stanley forecasting the global GLP-1 market could more than double between 2025 and 2035 to $190 billion, though competition from Novo Nordisk's Ozempic and Wegovy exists. The article notes Lilly's price-to-sales ratio of 14.4 is above its five-year average of 13.3, while its P/E of 43 is below the five-year average of 58, and says a pullback is possible.
- Enbridge vs. Enterprise Products: Which High-Yield Dividend Is Actually Safer?
The article compares Enterprise Products Partners (EPD) and Enbridge (ENB), two pipeline stocks with similar forward dividend yields of about 5.9% and 5.8% and roughly three decades of annual dividend increases. It finds EPD has stronger dividend coverage: distributions and buybacks equaled about 54% of cash flow from operations over the trailing 12 months through Q3, versus Enbridge's guided 60% to 70% of discretionary cash flow. EPD is also less leveraged, with debt-to-EBITDA around 2.9 compared with Enbridge's 4.5 to 5 target range. Although MLPs issue K-1s that complicate taxes, the article says EPD is still more tax-efficient, since Enbridge, as a Canadian corporation, is subject to withholding tax on dividends paid to U.S. investors. Enbridge stands out for its regulated natural gas utilities, which give it less cash flow volatility, and the article notes EPD's advantages could change over time.
- Jordi Visser Says One Overlooked Event Could Help Bitcoin Break Out Of Its Slump
According to the article, Visser links the pressure to heavy borrowing for AI. It also notes that Oracle has signaled it will not raise much money before June.
- 3 Unstoppable S&P 500 Stocks to Buy in November
The article highlights three S&P 500 stocks trading below previous highs: Netflix (NFLX) is down 52%, TJX (TJX) is down roughly 15% from its 52-week high, and DoorDash (DASH) is down 41% from its 2025 high. Netflix's revenue growth has slowed for four straight quarters, from nearly 18% in Q4 2025 to about 12% in Q3 2026, though its forward P/E of 17.7x is below the S&P 500's 19.2. TJX posted a 4% rise in second-quarter comparable sales and 11% adjusted EPS growth, with a forward P/E of 26. DoorDash's second-quarter revenue rose 24% to $4.5 billion, and its forward P/E of 29 compares with roughly 44% annualized earnings growth analysts expect. The article argues these factors could support market-beating returns.
- Binance says 90% of $6.3 billion hack losses are now covered, plans to resume withdrawals Sunday
Binance said it has covered up to 90% of the roughly $6.3 billion in tokens stolen from its hot wallets in a record crypto theft, and will keep buying the rest until coverage reaches 100%. The exchange said BTC, ETH, USDT, BNB, SOL, USDC, XRP, USD1, RLUSD and ZEC are fully backed, while the outstanding 10% consists of less liquid tokens outside its top 10. Funds come from its Secure Asset Fund for Users (SAFU), part of its Futures insurance fund and corporate treasury, and its next milestone is resuming withdrawals by Sunday, subject to security checks. The attack's method remains unclear: Binance first pointed to a compromised DevOps engineer's laptop, but co-CEO Richard Teng later said it involved a more complex process. TRM Labs pointed to North Korean hackers, citing similarities with the Bybit and KelpDAO hacks in April 2026.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.